FIIs and DIIs are piling into these four pharma stocks. Should you follow?

While rising institutional stakes highlight growing smart-money confidence in pharma, retail investors must weigh valuations, growth drivers, and regulatory risks before deciding whether to follow suit.
Read the full story on Mint Opens livemint.com in a new tab
Advertisement
CallZenixAI Voice Bot, Dialer & IVR SolutionsCloud dialer and contact-center software for your teamKnow more
This is a short summary of a story published by Mint, shown with a link to the original. The full story, photo and reporting belong to Mint.












